PinnedPublished inThe ADHD ReviewNew Book Alert: “Big Pharma Says You Have ADHD!”**FOR IMMEDIATE RELEASE**Mar 21, 2024A response icon2Mar 21, 2024A response icon2
From Boot Camp to Boardroom: Overcoming Post-Military Madness in the Business WorldAfter nearly 20 years working alongside military personnel, navigating the corridors of the federal prison system, and managing a bustling…2d ago2d ago
Published inOperational & Defense Psychology ReviewGeneral Anxiety: Conquering Your Fears, One Ridiculous Battle Tactic at a TimeLet’s talk about war. Not the kind waged with tanks and drones, but the war raging inside your own skull. The one where General Anxiety…5d ago5d ago
Published inThe ADHD ReviewPatient Perspectives: Experiences of Using Ozempic for ADHD ManagementBy Dr. Jerry D. Smith Jr.May 12May 12
Mastering the Art of Mental Push-Ups in the Corporate TrenchesTo my fellow Medium warriors, battle-tested veterans of the corporate grind, and caffeine-fueled survivors of yet another “quick” team sync…Apr 25Apr 25
Published inThe ADHD ReviewGLP-1 Agonists and Neurodevelopmental Disorders: Ozempic’s Emerging Role in ADHDBy Dr. Jerry D. Smith Jr., Clinical & Forensic PsychologistApr 22Apr 22
Field Guide to Mental Health: Spotting the Elusive Unicorn of Inner PeaceAfter nearly two decades of being a professional head-whisperer, including time spent untangling the psychological pretzels of military…Apr 18Apr 18
Today I Watched My Mother Die, and ChatGPT Held My HandI am a psychologist by training — a clinical and forensic one at that — someone who has spent the better part of a career helping others…Apr 5Apr 5
Published inThe ADHD ReviewInnovative Therapies: Assessing Ozempic’s Role in ADHD Treatment PlansBy Dr. Jerry D. Smith Jr, Clinical & Forensic PsychologistApr 1Apr 1
Published inThe ADHD ReviewFrom Blood Sugar to Behavior: How Ozempic May Impact ADHD SymptomsAs a clinical and forensic psychologist specializing in ADHD assessment and treatment, I’ve spent nearly two decades working with clients…Mar 25A response icon1Mar 25A response icon1
